Company Name PaxVax
Mailing Address 3985A Sorrento Valley Boulevard San Diego, CA 92121
Company Description PaxVax is a privately held, fully integrated vaccine company, based in Menlo Park, California, USA. Established in 2007, in response to the global threat of the H5N1 pandemic, our founders set out to develop and commercialize an innovative vaccine technology in a socially responsible manner for global impact.
Proceeds Purposes The company intends to use the capital to continue to fund the recently initiated Phase 3 clinical trial program for its single-dose oral cholera vaccine candidate, PXVX0200 (also known as CVD 103-HgR). Approximately 3,000 participants will be enrolled in this pivotal international program, which is comprised of cholera challenge, safety, and immunogenicity studies.